Foreign drug companies strongly opposed against insurance pricing policy on imported drugs.

Published: 1999-06-01 16:22:00

Updated: 1999-06-01 16:22:00

The foreign pharmaceutical corporations having their business in Korea expressed a total backlash against the MOHW insurance reimbursement price policy on the imported drugs, reducing the existing market prices of imported drugs by 40 to 80%, for which the foreign pharmaceutical community admitte...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK